Product Information
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.0408 per ML under NDC 71656002116. Its NADAC has been published 108 times since Sep 11, 2024.
FDA first approved this application on May 21, 2021. Its Orange Book therapeutic-equivalence code is AA.
Strength
1.5 g/15mL
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656002116
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211648FDA Approved
5/21/2021
TE Code
AA
On Market Since
10/5/2023
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has been published 108 times since Sep 11, 2024, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0408 per ML |
|---|---|
| All-time high | $0.0604 (Oct 16, 2024) |
| All-time low | $0.0279 (Nov 20, 2024) |
| 52-week high | $0.0414 |
| 52-week low | $0.0372 |
| Median price | $0.0397 |
| Average price | $0.0393 |
| Largest weekly change | -33.6% (Oct 23, 2024) |
| Weeks tracked | 108 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the POTASSIUM CHLORIDE ORAL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Saptalis Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
POTASSIUM CHLORIDE ORAL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID, manufactured by Saptalis Pharmaceuticals LLC, is $0.0408 per ML (NDC 71656002116), effective Sep 30, 2026.
How has the price of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has declined 32.3%. It has been tracked across 108 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
Since Sep 11, 2024, the NADAC for POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0279 (Nov 20, 2024) to a high of $0.0604 (Oct 16, 2024), with a median of $0.0397 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 10% (20 MEQ/15 ML) ORAL LIQUID (NDC 71656002116) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.